‹ Screener

Zura Bio Ltd

ZURA · Biological Products, (No Diagnostic Substances) · 95.0M shares · +1714%/yr ↑ dilution · EDGAR filings ↗

Reference price $6.25 · est. market cap ~$594M — last insider purchase, 2026-02-26 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

D44

Clinical/early-stage biotech — immunology clinical, well-funded.

Strengths

Risks

Notable findings

Key metrics

Return on equity
-67.6%
Return on assets
-60.2%
Current ratio
9.0×
Free cash flow
-$65M
EBITDA
-$75M
Tangible book value
$102M
Cash & investments
$109M
Cash runway
7q

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-02-26AI Biotechnology LLCBuy2.0M$6.25

All non-derivative Form 4 activity (SEC), newest first.

Notable events (8-K)

DateItems
2026-06-18Exec/director changeShareholder voteExhibitsfiling ↗
2026-05-22Exec/director changefiling ↗
2026-05-07ResultsReg FDExhibitsfiling ↗
2026-04-23Exec/director changeExhibitsfiling ↗
2026-03-19ResultsReg FDExhibitsfiling ↗
2026-03-10Reg FDExhibitsfiling ↗
2026-03-05Reg FDExhibitsfiling ↗
2026-02-26Material agreementResultsOtherExhibitsfiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-182026-06-170001104659-26-075826 ↗
8-K2026-05-222026-05-200001104659-26-065730 ↗
8-K2026-05-072026-05-070001628280-26-031701 ↗
10-Q2026-05-072026-03-310001628280-26-031696 ↗
8-K2026-04-232026-04-200001104659-26-047784 ↗
8-K2026-03-192026-03-190001104659-26-032077 ↗
10-K2026-03-192025-12-310001104659-26-032080 ↗
8-K2026-03-102026-03-100001104659-26-025520 ↗
8-K2026-03-052026-03-050001104659-26-023806 ↗
8-K2026-02-262026-02-240001104659-26-019827 ↗
8-K/A2026-02-262026-02-240001104659-26-020132 ↗
8-K2026-02-232026-02-210001104659-26-018312 ↗